Know Cancer

or
forgot password

    • cancer clinical trials in maywood, IL

    • Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin)
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Colorectal Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Leukemia
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Bladder Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Loyola University Medical Center
    Maywood, Illinois 60153
    Diarrhea, Radiation Enteritis
    S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Breast Cancer
    S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer
    S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin), Metastatic Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Prostate Cancer
    Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
    Loyola University Medical Center
    Maywood, Illinois 60153
    Esophageal Cancer, Gastric Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Lung Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lymphoma
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    Loyola University Medical Center
    Maywood, Illinois 60153
    Gastrointestinal Stromal Tumor
    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Multiple Myeloma
    O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin)
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    Leukemia
    S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Loyola University Medical Center
    Maywood, Illinois 60153
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Cancer-related Problem/Condition, Head and Neck Cancer, Pain
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
    Loyola University Medical Center
    Maywood, Illinois 60153
    Esophageal Cancer, Gastric Cancer
    S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
    Loyola University Medical Center
    Maywood, Illinois 60153
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Bladder Cancer
    Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
    Loyola University Medical Center
    Maywood, Illinois 60153
    Pancreatic Cancer, Perioperative/Postoperative Complications
    S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Breast Cancer
    ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer
    S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Breast Cancer
    S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
    Loyola University Medical Center
    Maywood, Illinois 60153
    Leukemia, Myelodysplastic Syndromes
    Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Kidney Cancer
    BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Pancreatic Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    CCI-779 in Treating Patients With Metastatic Melanoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin)
    BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Colorectal Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Sarcoma
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Colorectal Cancer
    S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    Leukemia
    PS-341 in Treating Patients With Metastatic Kidney Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Kidney Cancer
    S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Lung Cancer
    Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Colorectal Cancer
    Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Melanoma (Skin)
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Brain Tumor, Central Nervous System Tumor
    DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
    Loyola University Medical Center, Dept. of Hematology/Oncology
    Maywood, Illinois 60153
    Meningeal Neoplasms
    S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Lung Cancer
    S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Loyola University Medical Center
    Maywood, Illinois 60153
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Esophageal Cancer, Gastric Cancer
    Arsenic Trioxide in Treating Men With Germ Cell Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer